Skip to main content

You are here


Why are we there?  

  • Endemic/Epidemic disease

Our Work


  • Médecins Sans Frontières continues to work to improve the quality and availability of treatment for tuberculosis (TB).
  • Uzbekistan is one of many countries in Central Asia with high levels of drug-resistant TB (DR-TB).
  • Médecins Sans Frontières believes that introducing new approaches to diagnosis and treatment of TB – such as ambulatory care, rapid diagnostic tests and a comprehensive patient support programme including education, psychological support, transportation, food packages and financial aid – will help increase adherence to treatment and control the spread of the disease.


TB programme in Karakalpakstan

  • In the Autonomous Republic of Karakalpakstan, Médecins Sans Frontières runs a TB programme in collaboration with the Ministry of Health, helping patients manage the side effects of their drugs and providing psychosocial support to improve treatment adherence.
  • Many patients underwent treatment on an outpatient basis, so they avoided the additional stress of hospitalisation.
  • During 2014, Médecins Sans Frontières continued to enrol multidrug-resistant TB patients on a shorter, nine month regimen instead of the usual two years. The first people who started the regimen in 2013 finished their treatment, and Médecins Sans Frontières will continue to monitor them for 12 months to check that the TB does not return.


Treating HIV in Tashkent

  • Médecins Sans Frontières is also seeking to address the developing HIV epidemic in Tashkent, Uzbekistan’s capital city.
  • Teams continued to work at the Tashkent City AIDS Centre, and a total of 671 people were started on antiretroviral treatment. Psychosocial activities such as counselling were also provided. 


For the latest news on where we work visit:

Médecins Sans Frontières first worked in the country in 1997 and at the end of 2014, Médecins Sans Frontières had 246 staff in Uzbekistan. 

Related Stories